Literature DB >> 18249106

Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations.

Krisztina Czebe1, Imre Barta, Balázs Antus, Márta Valyon, Ildikó Horváth, Tamás Kullmann.   

Abstract

BACKGROUND: Exhaled breath condensate analysis is an attractive but still not fully standardised method for investigating airway pathology. Adherence of biomarkers to various condensing surfaces and changes in condensing temperature has been considered to be responsible for the variability of the results. Our aims were to compare the efficacy of different types of condensers and to test the influence of condensing temperature on condensate composition.
METHODS: Breath condensates from 12 healthy persons were collected in two settings: (1) by using three condensers of different type (EcoScreen, R-Tube, Anacon) and (2) by using R-Tube condenser either cooled to -20 or -70 degrees C. Condensate pH at standardised CO(2) level was determined; protein content was measured by the Bradford method and leukotrienes by EIA.
RESULTS: Breath condensates collected using EcoScreen were more alkaline (6.45+/-0.20 vs. 6.19+/-0.23, p<0.05 and 6.10+/-0.26, p<0.001) and contained more protein (3.89+/-2.03 vs. 2.65+/-1.98, n.s. and 1.88+/-1.99 microg/ml, p<0.004) as compared to the other devices. Only parameters obtained with R-Tube and Anacon correlated. Condensing temperature affected condensate pH (5.99+/-0.20 at -20 degrees C and 5.82+/-0.07 at -70 degrees C, p<0.05) but not protein content. Leukotriene B(4) was not found in any sample and cysteinyl-leukotriene was not found in condensates collected with R-Tube or Anacon.
CONCLUSION: Condenser type influences sample pH, total protein content and cysteinyl-leukotriene concentration. Condensing temperature influences condensate pH but not total protein content. These results suggest that adherence of the biomarkers to condenser surface and condensing temperature may play a role but does not fully explain the variability of EBC biomarker levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249106     DOI: 10.1016/j.rmed.2007.12.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  26 in total

1.  Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome.

Authors:  Balazs Antus; Imre Barta; Krisztina Czebe; Ildiko Horvath; Eszter Csiszer
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

2.  Drinking influences exhaled breath condensate acidity.

Authors:  Tamás Kullmann; Imre Barta; Balázs Antus; Ildikó Horváth
Journal:  Lung       Date:  2008-03-27       Impact factor: 2.584

3.  Efficacy of two breath condensers.

Authors:  A Davidsson; B Schmekel
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate.

Authors:  Jason S Debley; Arpy S Ohanian; Charles F Spiekerman; Moira L Aitken; Teal S Hallstrand
Journal:  Chest       Date:  2010-04-09       Impact factor: 9.410

Review 5.  Exhaled breath condensate collection in the mechanically ventilated patient.

Authors:  Stewart R Carter; Christopher S Davis; Elizabeth J Kovacs
Journal:  Respir Med       Date:  2012-03-06       Impact factor: 3.415

6.  Exhaled breath condensate pH in patients with cystic fibrosis.

Authors:  Balazs Antus; Imre Barta; Eszter Csiszer; Krisztina Kelemen
Journal:  Inflamm Res       Date:  2012-06-16       Impact factor: 4.575

7.  A mobile instrumentation platform to distinguish airway disorders.

Authors:  Michael Schivo; Felicia Seichter; Alexander A Aksenov; Alberto Pasamontes; Daniel J Peirano; Boris Mizaikoff; Nicholas J Kenyon; Cristina E Davis
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

8.  Differential cytokine pattern in the exhaled breath of patients with lung cancer.

Authors:  Tamás Kullmann; Imre Barta; Eszter Csiszér; Balázs Antus; Ildikó Horváth
Journal:  Pathol Oncol Res       Date:  2008-04-16       Impact factor: 3.201

9.  Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients.

Authors:  Rembert Koczulla; Silvano Dragonieri; Robert Schot; Robert Bals; Stefanie A Gauw; Claus Vogelmeier; Klaus F Rabe; Peter J Sterk; Pieter S Hiemstra
Journal:  Respir Res       Date:  2009-08-24

10.  Comparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices.

Authors:  Frank Hoffmeyer; Monika Raulf-Heimsoth; Volker Harth; Jürgen Bünger; Thomas Brüning
Journal:  BMC Pulm Med       Date:  2009-11-30       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.